{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:51:59Z","timestamp":1761490319257},"reference-count":0,"publisher":"Portico","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1358\/dot.2017.53.5.2630780","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T04:11:23Z","timestamp":1497931883000},"page":"271","source":"Crossref","is-referenced-by-count":5,"title":["Andexanet alpha: A recombinant mimetic of human factor Xa for the\nreversal of anticoagulant therapies"],"prefix":"10.3730","volume":"53","author":[{"family":"Escolar, G.","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Diaz-Ricart, M.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Arellano-Rodrigo, E.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1320","published-online":{"date-parts":[[2017]]},"container-title":["Drugs of Today"],"original-title":[],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T13:08:10Z","timestamp":1685452090000},"score":1,"resource":{"primary":{"URL":"http:\/\/access.portico.org\/stable?au=pjbf7dd7x3s"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":0,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1358\/dot.2017.53.5.2630780","relation":{},"ISSN":["1699-4019"],"issn-type":[{"value":"1699-4019","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}